- Home
- BHVN vs SRPT Comparison
BHVN vs SRPT Comparison
Compare BHVN & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHVN
- SRPT
- Stock Information
- Founded
- BHVN 2013
- SRPT 1980
- Country
- BHVN United States
- SRPT United States
- Employees
- BHVN N/A
- SRPT N/A
- Industry
- BHVN Biotechnology: Pharmaceutical Preparations
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- BHVN Health Care
- SRPT Health Care
- Exchange
- BHVN Nasdaq
- SRPT Nasdaq
- Market Cap
- BHVN 1.7B
- SRPT 1.9B
- IPO Year
- BHVN 2017
- SRPT 1997
- Fundamental
- Price
- BHVN $15.63
- SRPT $22.90
- Analyst Decision
- BHVN Strong Buy
- SRPT Hold
- Analyst Count
- BHVN 14
- SRPT 31
- Target Price
- BHVN $49.23
- SRPT $40.61
- AVG Volume (30 Days)
- BHVN 2.4M
- SRPT 6.5M
- Earning Date
- BHVN 11-11-2025
- SRPT 11-05-2025
- Dividend Yield
- BHVN N/A
- SRPT N/A
- EPS Growth
- BHVN N/A
- SRPT N/A
- EPS
- BHVN N/A
- SRPT N/A
- Revenue
- BHVN N/A
- SRPT $2,481,531,000.00
- Revenue This Year
- BHVN N/A
- SRPT $9.41
- Revenue Next Year
- BHVN $2,195.07
- SRPT N/A
- P/E Ratio
- BHVN N/A
- SRPT N/A
- Revenue Growth
- BHVN N/A
- SRPT 64.89
- 52 Week Low
- BHVN $12.79
- SRPT $10.42
- 52 Week High
- BHVN $55.70
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- BHVN 51.87
- SRPT 71.18
- Support Level
- BHVN $14.32
- SRPT $17.57
- Resistance Level
- BHVN $16.24
- SRPT $23.42
- Average True Range (ATR)
- BHVN 0.82
- SRPT 1.36
- MACD
- BHVN 0.11
- SRPT 0.61
- Stochastic Oscillator
- BHVN 60.92
- SRPT 77.97
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.